Australian based company Neuren pharmaceuticals is now recruiting for the second ever clinical trial into Angelman syndrome in Australia. Sites are located in Melbourne, Sydney and Brisbane.

• Confirmed diagnosis of Angelman syndrome (not mosaic)
• Male & Female
• Stable seizure profile
• >12kg weight

Further details and eligibility criteria can be found at angelmanstudy.com.au/ & clinicaltrials.gov/